Biotech NewsCEL-SCI (CVM)’s 73% Survival Finding Gets a Global Spotlight BioTech Health XSeptember 25, 2026 CEL-SCI Corporation (NYSE:CVM) has secured a keynote presentation for its head and neck cancer treatment at an international… 0 Shares 0 0 0 0 0 0 0